Providing TaSP When Stuck Between a Rock & a Hard Place
In the absence of universal antiretroviral (ARV) treatment, should we prioritize on providing HIV meds to the main drivers of the epidemic first before making them available to the rest of the population? This new theory from aidsmap says yes.
If countries followed the idea, it would mean injection drug users and female sex workers would be treated before all other at-risk groups.
Today, there are now more than 20 individual HIV drugs, known as antiretrovirals (ARVs), on the market to treat this disease, along with several combination drugs, and more are on the way.
Click here for a guided tour of all our easy-to-read treatment lessons, or use the index on each page to jump to a specific topic or lesson.
One More Study Shows PrEP Doesn’t Lead to Riskier Sex
PrEP was approved in 2012 as an HIV prevention tool that can reduce the risk of transmission by more than 90% if used correctly. However, the antiretroviral has remained controversial, and sparsely used, in no small part because of concerns that it will lead to sexual risk bingeing.
'Quad' Is As Effective As Older ARV Options, With Fewer Side Effects
The once-daily combination therapy Stribild,aka: the “Quad” because it contains 4 anitretrovirals, is just as effective as both Atripla therapy & a Reyataz plus Truvada combination. Plus, Stribild is far less likely to give you those crazy dreams, among other psychiatric side effects.
For more info, click here.
New HIV Care Guidelines
Now that antivirals have succeeded in giving a normal life span to many people with HIV, IDSA has urged clinicians to focus their energies outside of the virus and back to primary care.
“In many HIV practices now, 80% of patients with HIV infection have the virus under control. This means that primary care physicians need a better grasp of the impact HIV care has on routine health care. Doctors need to tell their HIV-infected patients, Your HIV disease is controlled, and we need to think about the rest of you.”
—Judith A. Aberg, MD, lead author of the new guidelines.
When Choosing Your First ARV Regimen, Please Note:
The HIV antiretroviral Sustiva (efavirenz), part of triple-therapy combo ATRIPLA, doubles the rate of suicidality—suicidal thoughts and behaviors—among those starting therapy for the first time. For more information, click here.
In a new report, the French health ministry made recommendations on HIV treatment, includingthe promotion of a “combined prevention” that associates behavioral measures, testing strategies and the adoption of antiretroviral (ARV) treatment for all people living with the virus in France.
PEP: In Case of Emergency
Post-exposure prophylaxis can stop HIV, but only if you and your health care providers know about it. Unfortunately, this still seems to be a big problem in the medical community at large….
This POZ exclusive asks: What’s the hold-up with PEP? How accessible is it? Where is it, and how can you be proactive about acquiring it?
Good News: Booze Doesn’t Affect Treatment Failure or CD4 Count!
Although, heavy drinkers are more likely to interrupt their antiretroviral (ARV) regimen.
Click here to read our aidsmap summary.